Article ; Online: Anti-Interleukin 23 Biologic Are Mostly Effective and Safe in Psoriatic Patients Who Failed Anti-Interleukin 17. A Real-Life, Retrospective 52-Week Experience.
2023 Volume 114, Issue 4, Page(s) T363–T365
| Title translation | [Artículo traducido] Los inhibidores selectivos de la IL23 son, en su mayoría, efectivos y seguros en pacientes con psoriasis y fallo previo a tratamientos biológicos anti IL-17. Una experiencia de práctica clínica real a 52 semanas. |
|---|---|
| MeSH term(s) | Humans ; Retrospective Studies ; Interleukin-23/therapeutic use ; Arthritis, Psoriatic/drug therapy ; Psoriasis/drug therapy ; Biological Products/adverse effects ; Treatment Outcome ; Antirheumatic Agents/therapeutic use ; Severity of Illness Index |
| Chemical Substances | Interleukin-23 ; Biological Products ; Antirheumatic Agents |
| Language | Spanish |
| Publishing date | 2023-02-15 |
| Publishing country | Spain |
| Document type | Case Reports |
| ZDB-ID | 390255-9 |
| ISSN | 1578-2190 ; 0001-7310 ; 1138-8196 |
| ISSN (online) | 1578-2190 |
| ISSN | 0001-7310 ; 1138-8196 |
| DOI | 10.1016/j.ad.2022.05.044 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Ui VI Zs.188: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.